AN OPEN LABEL PHASE I STUDY TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF HBI INACTIVATED HEPATITIS-A VACCINE WHEN ADMINISTERED AS A SINGLE DOSE IN TWO GROUPS OF HEALTHY SUBJECTS OF 19 TO 49 YEARS AND 12 TO 18 YEARS OF AGE - Hepatitis A Vaccine
Phase of Trial: Phase I
Latest Information Update: 21 Sep 2018
At a glance
- Drugs Hepatitis A vaccine (Primary)
- Indications Hepatitis A
- Focus Adverse reactions
- 11 Sep 2018 Status changed from recruiting to completed.
- 08 Jan 2018 Status changed from not yet recruiting to recruiting.
- 05 Jan 2018 New trial record